Pomegranate and Heart Health: Could This Ancient Fruit Help Treat Heart Failure?
Discover how pomegranates and urolithin A may support heart health, with promising early research into heart failure with preserved ejection fraction.
Introduction
Pomegranates have been valued for centuries for their nutritional benefits and distinctive ruby-red seeds. Originally associated with ancient Persia, present-day Iran, this fruit is now widely recognised as a source of antioxidants and other beneficial plant compounds.
However, emerging scientific research suggests that pomegranates may offer more than general nutritional benefits. Scientists are investigating a compound called urolithin A, which may have the potential to improve heart function and could eventually contribute to new approaches for treating a particular type of heart failure.
The findings are especially interesting because heart failure with preserved ejection fraction is a complex condition that remains challenging to treat. Although the research is still in its early stages, it highlights the potential connection between diet, gut bacteria and cardiovascular health.
What Makes Pomegranates Beneficial for Heart Health?
Pomegranates are rich in polyphenols, naturally occurring plant compounds known for their antioxidant properties. Antioxidants help protect cells against oxidative stress, which occurs when harmful molecules accumulate faster than the body can manage them.
Oxidative stress and inflammation have been associated with several chronic health conditions, including cardiovascular disease.
Pomegranates also provide dietary fibre, vitamin C, vitamin K and other nutrients that contribute to a balanced diet. Eating whole pomegranate seeds can increase fibre intake, while unsweetened pomegranate juice provides certain plant compounds without the same fibre content.
Although these nutritional qualities make pomegranates a valuable addition to a varied diet, their benefits should not be overstated. Eating pomegranates alone has not been proven to prevent or cure heart failure.
Researchers are now looking more closely at how specific compounds produced during digestion might influence the heart.
What Is Urolithin A?
Urolithin A is a compound produced when certain gut bacteria break down substances called ellagitannins and ellagic acid, which are found in foods such as pomegranates, walnuts and some berries.
Unlike vitamins and minerals, urolithin A is not present in substantial amounts in these foods in its final form. Instead, its production depends on how an individual's gut microbiome processes particular plant compounds.
This distinction is important because not everyone produces the same amount of urolithin A after eating these foods. Differences in gut bacteria can influence whether, and how efficiently, a person converts dietary compounds into this substance.
Scientists have previously investigated urolithin A for its potential role in mitochondrial health. Mitochondria are structures inside cells responsible for producing much of the energy the body needs to function.
Maintaining healthy mitochondria is particularly important for the heart, which continuously requires energy to pump blood throughout the body.
These findings have prompted researchers to explore whether urolithin A could also help address problems associated with heart failure.
Understanding Heart Failure With Preserved Ejection Fraction
Heart failure does not always mean that the heart has stopped working or can no longer pump blood. In some cases, the heart continues to pump a relatively normal proportion of the blood inside it but struggles to relax and fill properly between beats.
This condition is known as heart failure with preserved ejection fraction, or HFpEF.
HFpEF can cause symptoms such as breathlessness, fatigue, swelling in the legs and reduced ability to carry out everyday activities. It is commonly associated with ageing, high blood pressure, obesity, diabetes and other cardiovascular or metabolic conditions.
Because the heart's pumping percentage can remain within a relatively normal range, the condition may be difficult to recognise without appropriate medical assessment.
Treatment focuses on relieving symptoms, reducing the risk of hospitalisation, managing contributing conditions and improving quality of life. Certain medicines can also help reduce cardiovascular risks and improve outcomes.
Nevertheless, HFpEF remains a complex condition, making the search for additional treatment options an important area of medical research.
What Did the Researchers Discover?
Researchers at King's College London investigated whether urolithin A could influence the biological processes involved in HFpEF.
According to the reported findings, the team studied animal models and engineered human heart tissue. The results suggested that urolithin A improved the relaxation of heart muscle, reduced scarring and limited harmful enlargement of the heart.
The researchers also identified a possible mechanism involving a protein known as PKG1α. This protein plays a role in cellular signalling associated with blood vessel function and the relaxation of cardiovascular tissues.
In animal models, treatment with urolithin A reportedly improved certain measures of heart function by as much as 80%.
The researchers also observed improvements in engineered human heart tissue created using stem cell technology. This offers an additional way to investigate how the compound might affect human heart cells.
However, these findings must be interpreted carefully. Results obtained from animals and laboratory-grown tissues do not establish that the same improvements will occur in people living with heart failure.
The reported percentage also refers to particular measures of heart function in experimental models, not an 80% improvement in every patient's condition.
Could Eating More Pomegranates Produce the Same Results?
One of the most interesting questions is whether people can obtain similar benefits by eating foods that support the production of urolithin A.
Pomegranates are one source of the plant compounds involved in this process. Walnuts and certain berries can also provide relevant dietary compounds.
However, consuming these foods does not guarantee that someone will produce enough urolithin A to achieve the effects observed in laboratory experiments.
The amount produced varies between individuals, and researchers still need to establish whether increasing dietary intake of the relevant compounds can meaningfully improve heart function in people with HFpEF.
It is also important to distinguish between eating a whole fruit and taking a concentrated supplement. Supplements containing urolithin A may deliver different amounts of the compound than the body naturally produces through digestion.
Although early research has explored the compound's safety in humans, its effectiveness as a treatment for heart failure has not yet been established.
People should not start supplements or change prescribed medication without consulting a qualified healthcare professional.
What Does This Mean for the Future of Heart Failure Treatment?
The research offers an encouraging direction for scientists investigating new ways to support cardiovascular health.
If further studies confirm the findings, urolithin A could help researchers develop additional treatment strategies for HFpEF. It may also improve understanding of how mitochondrial function, cellular signalling and metabolic processes influence heart health.
Before the compound can be recommended as a treatment, researchers will need carefully designed clinical trials involving people with the condition. These studies must determine appropriate doses, assess potential side effects and establish whether the treatment improves meaningful outcomes, such as symptoms, exercise capacity and hospitalisation rates.
Scientists will also need to investigate whether dietary approaches that encourage urolithin A production can provide measurable benefits.
For now, pomegranates remain a nutritious food rather than a proven heart failure remedy.
Practical Ways to Support Heart Health
While research continues, several established lifestyle measures can help support cardiovascular health:
- Eat a balanced diet: Include fruits, vegetables, whole grains, legumes, nuts and other nutrient-rich foods.
- Manage blood pressure: Regular monitoring and appropriate treatment can help reduce cardiovascular risks.
- Stay physically active: Follow an activity plan suited to your health and fitness level, particularly if you have a diagnosed heart condition.
- Manage diabetes and cholesterol: Work with your healthcare team to monitor and control relevant risk factors.
- Avoid smoking: Smoking increases the risk of cardiovascular disease.
- Follow medical advice: Take prescribed medicines as directed and attend recommended follow-up appointments.
Anyone experiencing persistent breathlessness, unusual fatigue or swelling should seek medical advice. Sudden or severe chest pain or difficulty breathing requires emergency medical attention.
Conclusion
Pomegranates have long been appreciated for their nutritional value, and emerging research into urolithin A offers another reason for scientists to investigate their potential relationship with heart health.
Early experimental findings suggest that this gut-derived compound may improve certain aspects of heart function associated with HFpEF. However, further human clinical trials are essential before its effectiveness as a treatment can be confirmed.
In the meantime, enjoying pomegranates as part of a balanced diet can contribute to healthy eating habits. The most important takeaway is to view this research as a promising scientific development, not a substitute for established medical care.
Disclaimer
This article is intended for informational and educational purposes only and does not constitute medical advice, diagnosis or treatment. The research discussed is preliminary, and urolithin A and pomegranates have not been established as cures for heart failure. Individual health needs vary, so consult a qualified healthcare professional before making changes to your diet, taking supplements or altering prescribed medication. If you suspect a medical emergency, seek immediate medical assistance.
